Cost items in melanoma patients by clinical characteristics and time from diagnosis
cost of illness; direct costs; health economics; healthcare assessment; healthcare services research; melanoma; specific costs
Oncology
melanoma
cost of illness
health economics
healthcare assessment
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
specific costs
direct costs
RC254-282
3. Good health
DOI:
10.3389/fonc.2023.1234931
Publication Date:
2023-11-09T15:10:01Z
AUTHORS (15)
ABSTRACT
Costs related to the care of melanoma patients have been rising over past few years due increased disease incidence as well introduction innovative treatments. The aim this study is analyse CMM cost items based on stage at diagnosis, together with other diagnostic and prognostic characteristics melanoma. Analyses were performed 2,647 incident cases invasive that registered in 2015 2017 Veneto Cancer Registry (RTV). Direct melanoma-related costs per patient calculated for each year ranging from 2 before diagnosis 4 after, stratified by such outpatient services, inpatient drug prescriptions, hospital admissions, hospice emergency room treatment. Average yearly compared according available clinical-pathological characteristics. Lastly, log-linear multivariable analysis was investigate potential drivers among these Overall, average direct are highest first after (€2,903) then decrease time. Hospitalization 8 16 times higher than subsequent years, while services drugs gradually When it observed expenditure associated more advanced stages mainly use. results present show grouping tumour can improve our understanding different cutaneous malignant experience hospitalization services. Policy makers should consider overall stage-specific annual when allocating resources management patients.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (43)
CITATIONS (1)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....